Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2
Rohitash Yadav, Mohammed Imran, Puneet Dhamija, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 12, pp. 4433-4448
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
Rohitash Yadav, Jitendra Kumar Chaudhary, Neeraj Jain, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 821-821
Open Access | Times Cited: 385
A review on drug repurposing applicable to COVID-19
Serena Dotolo, Anna Marabotti, Angelo Facchiano, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 726-741
Open Access | Times Cited: 162
Different mutations in SARS-CoV-2 associate with severe and mild outcome
Ádám Nagy, Sándor Pongor, Balázs Győrffy
International Journal of Antimicrobial Agents (2020) Vol. 57, Iss. 2, pp. 106272-106272
Open Access | Times Cited: 145
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wenbing Wu, Ying Cheng, Hong Zhou, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 140
The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
Nicholas A. Wong, Milton H. Saier
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1308-1308
Open Access | Times Cited: 121
SARS-CoV-2 Drug Resistance and Therapeutic Approaches
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly
Rajan Rolta, Rohitash Yadav, Deeksha Salaria, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 18, pp. 7017-7034
Open Access | Times Cited: 101
Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods
Alireza Poustforoosh, Hassan Hashemipour, Burak Tüzün, et al.
Biophysical Chemistry (2021) Vol. 272, pp. 106564-106564
Open Access | Times Cited: 66
A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation
Ahmed Rakib, Zulkar Nain, Saad Ahmed Sami, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 2, pp. 1476-1498
Open Access | Times Cited: 65
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 10
Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2
Rohitash Yadav, Mohammed Imran, Puneet Dhamija, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 17, pp. 6617-6632
Open Access | Times Cited: 60
Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2
Rohitash Yadav, Shazia Hasan, Sumit Kumar Mahato, et al.
Journal of Molecular Liquids (2021) Vol. 342, pp. 116942-116942
Open Access | Times Cited: 47
3D‐QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl‐2 family proteins for targeting U‐87 glioblastoma
Alireza Poustforoosh, Sanaz Faramarz, Mohammad Hadi Nematollahi, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 2, pp. 390-405
Closed Access | Times Cited: 45
Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic
Meenakshi Negi, Pooja A. Chawla, Abdul Faruk, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104315-104315
Open Access | Times Cited: 48
HIV and SARS CoV‐2 coinfection: A retrospective, record‐based, case series from South India
Janakiram Marimuthu, Bubby S. Kumar, Aravind P. Gandhi
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 163-165
Open Access | Times Cited: 47
Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2
Poonam Dhankhar, Vikram Dalal, Vishakha Singh, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 9, pp. 4084-4099
Open Access | Times Cited: 40
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity
Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2949-2949
Open Access | Times Cited: 36
Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
Tatsuhito Matsuo
Biology (2021) Vol. 10, Iss. 6, pp. 454-454
Open Access | Times Cited: 33
Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug
Bo Zhang, Junjie Tian, Qintao Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 25
Discovering broad-spectrum inhibitors for SARS-CoV-2 variants: a cheminformatics and biophysical approach targeting the main protease
Safar M. Alqahtani
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Computational drug repurposing study of the RNA binding domain of SARS‐CoV‐2 nucleocapsid protein with antiviral agents
Gizem Tatar, Ezgi Ozyurt, Kemal Turhan
Biotechnology Progress (2020) Vol. 37, Iss. 2
Open Access | Times Cited: 36
Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study
Deblina Rababi, Anish Nag
3 Biotech (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 11
Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function
Irene Boniardi, Angela Corona, J. Basquin, et al.
Virus Research (2023) Vol. 336, pp. 199221-199221
Open Access | Times Cited: 9
Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study
Vanderlan Nogueira Holanda, Elton Marlon de Araújo Lima, Welson Vicente da Silva, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 12, pp. 5462-5480
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top